Market: NASD |
Currency: USD
Address: 420 Stevens Avenue
Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.
📈 Evoke Pharma, Inc. Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
$18.00
-
Upside/Downside from Analyst Target:
227.87%
-
Broker Call:
2
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
50-100%
-
Net Income Growth Range (1Y):
10-25%
-
Revenue Growth Range (1Y):
50-100%
-
Upcoming Earnings Date:
-
💰 Dividend History
| Year |
Annual Yield (%) |
Total Amount |
Current Yield (%) |
Ex Date |
Pay Date |
Particulars |
| 2024 |
- |
$0.083333 |
- |
2024-08-01 |
- |
Stock split |
|
Total Amount for 2024: $0.083333 |
| 2022 |
- |
$0.083333 |
- |
2022-05-23 |
- |
Stock split |
|
Total Amount for 2022: $0.083333 |
📅 Earnings & EPS History for Evoke Pharma, Inc.
| Date | Reported EPS |
|---|
| 2025-08-14 | -0.62 |
| 2025-05-13 | -0.51 |
| 2025-03-13 | -0.77 |
| 2024-11-07 | -0.94 |
| 2024-08-13 | -0.93 |
| 2024-05-14 | -2.04 |
| 2024-03-14 | -7.08 |
| 2023-11-09 | -6.12 |
| 2023-08-10 | -6.72 |
| 2023-05-15 | -8.04 |
| 2023-03-21 | -6.36 |
| 2022-11-09 | -7.2 |
| 2022-08-10 | -8.52 |
| 2022-05-10 | -10.08 |
| 2022-03-08 | -8.64 |
| 2021-11-10 | -8.64 |
| 2021-08-12 | -10.08 |
| 2021-05-12 | -11.52 |
| 2021-03-11 | -12.96 |
| 2020-11-10 | -11.52 |
| 2020-08-06 | -40.32 |
| 2020-05-12 | -10.08 |
| 2020-03-12 | -8.64 |
| 2019-11-07 | -10.08 |
| 2019-08-08 | -12.96 |
📰 Related News & Research
No related articles found for "evoke pharma".
